George Jacob, Greenberg Shai, Barshack Iris, Goldberg Iris, Keren Gad, Roth Arie
Cardiovascular Research Laboratory, Department of Cardiology, Tel-Aviv Sourasky Medical Center, Tel Aviv University Sackler School of Medicine, 6 Weizman St., Israel.
Atherosclerosis. 2003 May;168(1):33-8. doi: 10.1016/s0021-9150(03)00055-8.
Inflammation occurring consequent to vessel injury is thought to play an important role in atherosclerosis and restenosis. Autoimmunity to HSP65 has been shown to accelerate early atherogenesis in rabbits and mice, whereas in humans epidemiological data support this contention. In the current study, we explored the possibility of HSP65 influencing the extent of neointimal growth in the rat carotid injury model. Rats were either immunized with recombinant mycobacterial HSP65, heat killed preparation of Mycobacterium tuberculosis (MT), or with PBS, all emulsified in incomplete Freund's adjuvant. Animals were boosted with a similar protocol 3 weeks following the primary immunization and 2 weeks later carotid injury was applied in all animals by balloon inflation. Upon sacrifice 2 weeks later, sera were obtained for measurement of anti-HSP65 antibodies by ELISA, splenocytes were assessed for proliferative response to in vitro priming with HSP65, and carotid arteries were removed for evaluation of neointimal growth. Rats immunized with HSP65 exhibited a brisk and sustained humoral immune response to HSP65, and cellular immunity was also evident by thymidine uptake to splenocytes primed with the respective protein. Neointimal/medial ratio was significantly increased in HSP65 immunized rats, in comparison with MT injected and control animals. In conclusion, immunity to HSP65 can play a role in accelerating restenosis following arterial injury. These results should be further investigated in humans as they may provide a possible link between infections and restenosis/accelerated arteriosclerosis.
血管损伤后发生的炎症被认为在动脉粥样硬化和再狭窄中起重要作用。对热休克蛋白65(HSP65)的自身免疫已被证明可加速兔和小鼠的早期动脉粥样硬化形成,而在人类中,流行病学数据支持这一观点。在本研究中,我们探讨了HSP65影响大鼠颈动脉损伤模型中新内膜生长程度的可能性。将大鼠分别用重组分枝杆菌HSP65、热灭活的结核分枝杆菌(MT)制剂或PBS免疫,所有这些均与不完全弗氏佐剂乳化。在初次免疫后3周,按照类似方案对动物进行加强免疫,2周后对所有动物通过球囊扩张造成颈动脉损伤。2周后处死动物,采集血清通过酶联免疫吸附测定(ELISA)法检测抗HSP65抗体,评估脾细胞对用HSP65进行体外致敏的增殖反应,并取出颈动脉评估新内膜生长情况。用HSP65免疫的大鼠对HSP65表现出活跃且持续的体液免疫反应,通过对用相应蛋白致敏的脾细胞摄取胸苷也可明显看出细胞免疫。与注射MT的动物和对照动物相比,用HSP65免疫的大鼠的新内膜/中膜比值显著增加。总之,对HSP65的免疫可在加速动脉损伤后的再狭窄中起作用。这些结果应在人类中进一步研究,因为它们可能提供感染与再狭窄/加速动脉粥样硬化之间的可能联系。